Clinical Trials Directory

Trials / Conditions / Ovarian Cancer Stage III

Ovarian Cancer Stage III

13 registered clinical trials studyying Ovarian Cancer Stage III — 7 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients
NCT05479045
Georgetown UniversityPhase 2
RecruitingTart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
NCT06268665
University of California, DavisPhase 2
RecruitingTumor Microenvironment in Ovarian Cancer
NCT06272240
University of Udine—
RecruitingPredicting Outcome of Cytoreduction in Advanced Ovarian Cancer
NCT06017557
Fondazione Policlinico Universitario Agostino Gemelli IRCCSN/A
RecruitingMicrodevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
NCT04701645
Brigham and Women's HospitalPhase 1
UnknownDynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments
NCT06025045
Jing Li—
RecruitingExercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving
NCT04997096
Dana-Farber Cancer InstituteN/A
UnknownPARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer
NCT05187208
Seoul National University HospitalPhase 4
Active Not RecruitingOregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian C
NCT04938583
CanariaBio Inc.Phase 1 / Phase 2
RecruitingPrehabilitation in Gynaecological Cancer Patients
NCT04789694
Charles University, Czech RepublicPhase 3
CompletedSelf-Advocacy Serious Game in Advanced Cancer
NCT03339765
University of PittsburghN/A
TerminatedThe Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian
NCT03162562
CanariaBio Inc.Phase 1
CompletedImpact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer
NCT02258165
Queensland Centre for Gynaecological Cancer—